title: Should beta-blocking agents be used in thyrotoxic heart disease?
authors.affiliation: Department of Medicine, Prince of Wales Hospital, Shatin, Hong Kong.
authors.forename: G T
authors.initials: GT
authors.lastname: Ko
authors.forename: C C
authors.initials: CC
authors.lastname: Chow
authors.forename: J E
authors.initials: JE
authors.lastname: Sanderson
authors.forename: V T
authors.initials: VT
authors.lastname: Yeung
authors.forename: C S
authors.initials: CS
authors.lastname: Cockram
mesh_terms: D000328:Adult; D017809:Fatal Outcome; D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000009:adverse effects*; D013971:Thyrotoxicosis / Q000150:complications*
chemical_list: D011433:Propranolol